Your browser doesn't support javascript.
loading
Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study.
Tawbi, Hussein A; Forsyth, Peter A; Hodi, F Stephen; Algazi, Alain P; Hamid, Omid; Lao, Christopher D; Moschos, Stergios J; Atkins, Michael B; Lewis, Karl; Postow, Michael A; Thomas, Reena P; Glaspy, John; Jang, Sekwon; Khushalani, Nikhil I; Pavlick, Anna C; Ernstoff, Marc S; Reardon, David A; Kudchadkar, Ragini; Tarhini, Ahmad; Chung, Caroline; Ritchings, Corey; Durani, Piyush; Askelson, Margarita; Puzanov, Igor; Margolin, Kim A.
Afiliación
  • Tawbi HA; University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: HTawbi@mdanderson.org.
  • Forsyth PA; Department of Neuro-Oncology, Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
  • Hodi FS; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Algazi AP; Melanoma Center, University of California-San Francisco, San Francisco, CA, USA.
  • Hamid O; Melanoma Center, The Angeles Clinic and Research Institute, Los Angeles, CA, USA.
  • Lao CD; Department of Dermatology, University of Michigan, Ann Arbor, MI, USA.
  • Moschos SJ; Division of Hematology & Oncology, The University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
  • Atkins MB; Department of Medical Oncology, Georgetown-Lombardi Comprehensive Cancer Center, Washington DC, USA.
  • Lewis K; Department of Medical Oncology, University of Colorado Comprehensive Cancer Center, Aurora, CO, USA.
  • Postow MA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Thomas RP; Department of Neurology, Stanford University Cancer Center, Stanford, CA, USA.
  • Glaspy J; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA, USA.
  • Jang S; Inova Schar Cancer Institute, Fairfax, VA, USA.
  • Khushalani NI; Department of Cutaneous Oncology, H Lee Moffitt Cancer Center, Tampa, FL USA.
  • Pavlick AC; Department of Medical Oncology, Weill Cornell Medicine, New York, NY, USA.
  • Ernstoff MS; Department of Immuno-Oncology, Division of Cancer Treatment and Diagnosis, National Cancer Institute at the National Institutes of Health, Rockville, MD, USA.
  • Reardon DA; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Kudchadkar R; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA.
  • Tarhini A; Departments of Cutaneous Oncology and Immunology, Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
  • Chung C; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ritchings C; Bristol Myers Squibb, Princeton, NJ, USA.
  • Durani P; Bristol Myers Squibb, Princeton, NJ, USA.
  • Askelson M; Bristol Myers Squibb, Princeton, NJ, USA.
  • Puzanov I; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Margolin KA; Department of Medical Oncology, City of Hope, Duarte, CA, USA.
Lancet Oncol ; 22(12): 1692-1704, 2021 12.
Article en En | MEDLINE | ID: mdl-34774225
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Protocolos de Quimioterapia Combinada Antineoplásica / Melanoma Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Protocolos de Quimioterapia Combinada Antineoplásica / Melanoma Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article